Editas Medicine Inc (EDIT) Stock: Navigating Market Highs and Lows in 52 Weeks

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Editas Medicine Inc’s current trading price is -21.40% away from its 52-week high, while its distance from the 52-week low is 54.20%. The stock’s price range for this period has been between $6.08 and $11.93 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.07 million for the day, a number notably lower than the average daily volume of 1.54 million over the last three months.

The present stock price for Editas Medicine Inc (EDIT) is $9.38. In the last trading session, the stock made a considerable jump, reaching $8.97 after an opening price of $8.88. The stock briefly fell to $8.53 before ending the session at $8.78.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Editas Medicine Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $11.93 on 02/03/23, while the lowest price for the same duration was marked at $6.08 on 10/23/23.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Editas Medicine Inc (EDIT) has experienced a quarterly rise of 8.76% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 765.66M and boasts a workforce of 226 employees.

Editas Medicine Inc: What Analysts Are Saying

As of right now, 6 analysts are rating Editas Medicine Inc as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 9 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 1 analyst is rating the stock as SELL.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 8.13, with a change in price of +1.06. Similarly, Editas Medicine Inc recorded 1,505,705 in trading volume during the last 100 days, posting a change of +12.62%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for EDIT stands at 0.10. Similarly, the long-term debt-to-equity ratio is also 0.07.

EDIT Stock Stochastic Average

As of today, Editas Medicine Inc’s raw stochastic average for the last 50 days stands at 92.63%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 92.63%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 90.16% and 83.85%, respectively.

EDIT Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The index has shown a price gain of 5.69% this year. Over the last six months, there has been a weaker performance of 0.59%. The price of EDIT fallen by 45.80% during the last 30 days period. For the last 5-days stocks have improved 22.23%.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts